MS
GILD icon

Maven Securities’s Gilead Sciences GILD Stock Holding History

Maven Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,983
Closed -$530K – 864
2025
Q1 		$558K Buy
+4,983
New +$514K 0.02% 567
2023
Q3 		– Sell
-6,580
Closed -$506K – 1137
2023
Q2 		$507K Buy
+6,580
New +$525K 0.01% 616
2022
Q4 		– Sell
-14,539
Closed -$1.15M – 952
2022
Q3 		$897K Buy
+14,539
New +$917K 0.02% 581
2022
Q1 		– Sell
-3,503
Closed -$224K – 1019
2021
Q4 		$254K Buy
+3,503
New +$241K 0.01% 731
2021
Q1 		– Sell
-20,269
Closed -$1.31M – 1213
2020
Q4 		$1.18M Buy
20,269
+4,756
+31% +$287K 0.12% 214
2020
Q3 		$974K Buy
15,513
+9,132
+143% +$633K 0.08% 253
2020
Q2 		$491K Buy
+6,381
New +$489K 0.03% 320
2017
Q1 		– Sell
-476
Closed -$34K – 53
2016
Q4 		$34K Buy
+476
New +$35.4K 0.03% 38

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Maven Securities's GILD Position: Q2 2025 in Review

Maven Securities sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 4,983 shares — an estimated $530K sold.

Maven Securities first reported a position in GILD in Q4 2016 and held it in 8 quarters. The position peaked at $1.18M in Q4 2020. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Maven Securities reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 4,983 Gilead Sciences shares in Q2 2025, an estimated $530K.
  • Maven Securities first reported a position in Gilead Sciences in Q4 2016 and held it in 8 quarters.
  • Maven Securities's Gilead Sciences position peaked at $1.18M in Q4 2020.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.